Marc Loire Fashions Launches Rs. 21 Crore IPO to Fund Retail Expansion

New Delhi [India], June 26: Marc Loire Fashions Limited, a fast-growing player in India’s women’s footwear market, has announced its Initial Public Offering (IPO) to raise ₹21 crore. The issue opens for subscription on June 30, 2025, and closes on July 2, 2025. The shares will be listed on the BSE SME platform.

The public offering comprises 21 lakh equity shares at a fixed price of ₹100 per share. Proceeds from the IPO will be used to:

•Open 15 new Exclusive Brand Outlets (EBOs)

•Upgrade retail infrastructure

•Meet working capital requirements

•Address general corporate purposes

Founded in 2014, Marc Loire has evolved into a fashion-forward brand offering over 800 SKUs, spanning categories such as heels, sneakers, boots, and ethnic footwear. The company was converted into a public limited entity in 2024.

Financial Highlights

The company has demonstrated strong top-line and bottom-line growth:

•Revenue (₹ crore): FY23 – 37.44 | FY24 – 40.40 | FY25 – 42.46

•PAT Margin (%): FY23 – 1.75% | FY24 – 10.09% | FY25 – 11.08%

•Return on Net Worth (RONW): 43.75%

•EBITDA margins: On an improving trajectory

Post-issue, the company’s net worth is expected to increase from ₹10.75 crore to ₹31.75 crore. The IPO is priced at a P/E multiple of 10.63x, suggesting a reasonably valued entry for investors.

Distribution Strategy

Marc Loire operates through a robust omnichannel model, combining Direct-to-Consumer (D2C) online sales with Business-to-Business (B2B) retail partnerships and Shop-in-Shop (SiS) formats. The company maintains relationships with over 40 vendors to ensure supply chain efficiency and product quality.

Market Opportunity

India’s ₹55,000 crore footwear industry is growing at a CAGR of 15%. With women’s footwear representing an increasing share of this market, Marc Loire is well-positioned to tap into the demand for affordable, trend-driven designs.

Promoters & Management

The leadership team includes:

•Arvind Kamboj – Managing Director & Chairman

•Shaina Malhotra – Whole-Time Director

•Atul Malhotra – Non-Executive Director

Each brings more than a decade of domain expertise in the fashion and footwear sectors.

IPO Details at a Glance:

•Issue Size: ₹21 crore

•Issue Price: ₹100 per share

•Lot Size: To be announced

•Subscription Period: June 30 – July 2, 2025

•Listing Exchange: BSE SME

For investors seeking exposure to a growing consumer brand with strong financials and expansion potential, Marc Loire Fashions offers a compelling opportunity to participate in the next phase of India’s retail fashion growth story.

If you object to the content of this press release, please notify us at [email protected]. We will respond and rectify the situation within 24 hours.

Business

Jinkushal Industries Limited Announces Unaudited Financial Results for the Quarter Ended June 30, 2026

Standalone Revenue Grows 37.4% YoY | Consolidated Revenue Grows 15.9% YoY The Board of Directors of Jinkushal Industries Limited (“Jinkushal” or “the Company”), at its meeting held today, approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, prepared in accordance with applicable provisions of the Companies Act, 2013, SEBI […]

Read More
Business G. S. Grewal Tractor and Mechanization Association

G. S. Grewal Appointed President of Tractor and Mechanization Association (TMA) for 2026–28

Tractor and Mechanization Association (TMA) has appointed Mr. G. S. Grewal as its President for the 2026–28 term. New Delhi [India], August 15: The Tractor and Mechanization Association (TMA), the apex industry body representing India’s tractor and farm mechanization sector, has appointed Mr. G. S. Grewal as its President for the 2026–28 term. The announcement was made […]

Read More
Business

Sanjivani Parenteral Limited Reports Q1 FY27 Results; EBITDA stood at Rs. 43.21 Mn with PAT at Rs. 24.91 Mn

Mumbai (Maharashtra) [India], August 14: Sanjivani Paranteral Limited (Sanjivani, The Company) (BSE: 531569), one of the emerging players in the pharmaceutical and healthcare manufacturing sector, continued to strengthen its operational performance during the year through improved efficiencies, focused execution, and a customer-centric approach across its business segments, and has announced its Unaudited Financial Results for Q1 […]

Read More